Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-09 Sale | 2023-06-09 7:55 pm | FIBROGEN INC | FGEN | Brennan Aoife Director | 4,733 | $17.19 | $81,367 | 40,613 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 4:15 pm | SYNLOGIC INC. | SYBX | Brennan Aoife See Remarks | 19,042 | $0.5758 | $10,964 | 256,301 (Direct) | View |
| 2022-04-04 Sale | 2022-04-06 4:39 pm | SYNLOGIC INC. | SYBX | Brennan Aoife See Remarks | 8,894 | $2.4459 | $21,754 | 275,343 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-27 Option Award | 2024-06-27 7:05 pm | N/A 2034-06-26 | Eliem Therapeutics Inc. | ELYM | Brennan Aoife President and CEO | 825,000 | $0 | 825,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:10 pm | N/A 2034-06-12 | Xilio Therapeutics Inc. | XLO | Brennan Aoife Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 8:00 pm | N/A 2034-06-04 | FIBROGEN INC | FGEN | Brennan Aoife Director | 70,000 | $0 | 70,000 (Direct) | View |
| 2023-11-10 Disposition | 2023-11-14 7:23 pm | N/A 2027-05-15 | SYNLOGIC INC. | SYBX | Brennan Aoife President and CEO | 147,214 | $0 | 147,214 (Direct) | View |
| 2023-11-10 Option Award | 2023-11-14 7:23 pm | N/A 2027-05-15 | SYNLOGIC INC. | SYBX | Brennan Aoife President and CEO | 147,214 | $0 | 147,214 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 7:55 pm | N/A 2033-06-06 | FIBROGEN INC | FGEN | Brennan Aoife Director | 20,955 | $0 | 40,613 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 9:08 pm | N/A 2032-06-15 | FIBROGEN INC | FGEN | Brennan Aoife Director | 41,461 | $0 | 50,075 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 4:05 pm | N/A 2032-02-04 | SYNLOGIC INC. | SYBX | Brennan Aoife See Remarks | 541,080 | $0 | 718,397 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 7:01 pm | N/A 2031-05-25 | FIBROGEN INC | FGEN | Brennan Aoife Director | 12,500 | $0 | 16,414 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 4:50 pm | N/A 2031-03-10 | SYNLOGIC INC. | SYBX | Brennan Aoife See Remarks | 356,250 | $0 | 462,317 (Direct) | View |
| 2020-08-05 Option Award | 2020-08-07 7:45 pm | N/A 2030-08-05 | FIBROGEN INC | FGEN | Brennan Aoife Director | 20,810 | $0 | 20,810 (Direct) | View |
Ownership | 2020-08-07 7:25 pm | N/A N/A | FIBROGEN INC | FGEN | Brennan Aoife Director | 0 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:00 am | N/A 2029-06-11 | Ra Pharmaceuticals Inc. | RARX | Brennan Aoife Director | 40,000 | $0 | 0 (Direct) | View |
| 2020-03-10 Option Award | 2020-03-12 6:00 pm | N/A 2030-03-10 | SYNLOGIC INC. | SYBX | Brennan Aoife See Remarks | 231,600 | $0 | 291,367 (Direct) | View |